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Abstract
IMPORTANCE Severe chronic pediatric pain causes individual suffering and significantly affects
social functioning and psychological well-being. For children with high pain severity, intensive
interdisciplinary pain treatment (IIPT) is a well-established treatment. However, across specialized
centers, it is not sufficient for all patients.
OBJECTIVE To evaluate the effectiveness of a psychosocial aftercare (PAC) program for pediatric
patients with severe chronic pain followed up for 6 months after discharge from IIPT.
DESIGN, SETTING, AND PARTICIPANTS This multicenter randomized clinical trial with 4
assessment points (pre-IIPT, immediately post-IIPT, 3 months, and 6 months) was conducted at 3
pediatric specialized tertiary care pain centers in Germany between September 11, 2018, and March
31, 2020. Included patients were aged 8 to 17 with a severe chronic pain condition who had been
admitted for IIPT. Data were analyzed from June 8 to September 4, 2020.
INTERVENTIONS Patients and their families were randomly assigned to 1 of 2 study groups at
inpatient IIPT admission. Both groups received standardized 3- to 4-week IIPT. After IIPT discharge,
the intervention group received PAC and the control group received usual care. PAC involved ongoing
contact with a social worker for as long as the family requested the support, up to a maximum of
6 months.
MAIN OUTCOMES AND MEASURES The primary outcome measure was pain at 6 months,
measured using the Chronic Pain Grading (CPG), an instrument based on an algorithm indicating
severity of the chronic pain disorder. Secondary outcomes included other pain-related and emotional
parameters.
RESULTS A total of 419 patients were randomized (mean [SD] age, 14.3 [2.1] years; 303 [72.3%]
girls; 116 [27.7%] boys), with 218 assigned to usual care and 201 assigned to PAC. At baseline in both
groups, the median (IQR) CPG was 3 (2-4). Superiority of PAC compared with usual care was
demonstrated at 6 months (median [IQR] CPG: usual care, 2 [2-3]; PAC, 1 [1-2]; r = 0.30; 95% CI, 0.17-
0.41). Additionally, PAC significantly improved emotional parameters (eg, significant time × group
interaction: b = −8.84; P < .001).
CONCLUSIONS AND RELEVANCE This randomized clinical trial found that PAC improved pain-
related and emotional parameters during the intervention 6 months after discharge from IIPT. Future
research is needed to investigate the intervention’s long-term effects.
(continued)
Key Points
Question Does a psychosocial aftercare
program (PAC) after in-hospital
intensive interdisciplinary pain
treatment (IIPT) for pediatric patients
with chronic pain improve functional
outcomes?
Findings In this randomized clinical trial
including 419 patients aged 8 to 17 years
randomized and 222 patients analyzed
at 6 months, PAC significantly improved
all pain-related as well as emotional
outcome parameters compared with
treatment as usual.
Meaning These findings suggest PAC
should be considered in IIPT for
pediatric chronic pain and its
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Introduction
Intensive interdisciplinary pain treatment (IIPT) is a well-established treatment for severe pediatric
chronic pain.1 While this specialized treatment demonstrates long-term effectiveness for many
patients, some do not benefit sufficiently.2,3 In the absence of empirical data, clinical observations
indicate a plausible source of risk for treatment failure: after a short intensive treatment of 3 to 4
weeks,1 patients may have difficulty generalizing and maintaining individual therapy goals during the
transition from highly structured, clinician-led support to self-reliance in everyday life. For example,
patients with psychological comorbidities often do not engage with a psychotherapist after IIPT,
despite this being recommended.4 The transtheoretical model5 highlights that changing maladaptive
health behaviors can be challenging. Consolidating and generalizing the active behavior learnt during
treatment requires a substantial change in coping efforts. Interventions supporting transition from
clinician-led treatment to self-determined use of learned strategies have been assessed in other
chronic health conditions. Meta-analyses provide evidence that clinician-led multicomponent
interventions (eg, parent education or behavioral training) can empower pediatric patients with
chronic health conditions, such as asthma or diabetes, to self-reliantly follow their treatment plan,
leading to improvements in disease management and disease severity.6 In light of this evidence, an
adjunctive family-centered treatment module for severe chronic pain was developed: personalized
psychosocial aftercare (PAC), which aims to provide support for pediatric patients and their families
in adherence to discharge recommendations and facilitate maintenance of IIPT treatment outcomes.
To test the effectiveness of PAC as an adjunctive IIPT treatment module, we conducted a
multicenter randomized clinical trial comparing treatment effectiveness in patients receiving PAC
compared with patients receiving usual aftercare. A real-world study design was chosen to compare
these aftercare strategies in a typical clinical setting. We expected that PAC would lead to greater
improvements in pain severity (incorporating pain intensity and functional impairment) and other
pain-related and psychological outcomes compared with usual care 3 and 6 months after discharge.
Moreover, we expected that at both time points, patients who received PAC would show greater
overall therapy satisfaction and greater adherence to therapy recommendations than patients who
received usual care.
Methods
This randomized clinical trial was approved by the ethics committees of Witten/Herdecke University,
Baden-Wuerttemberg State Chamber for Medicine, and the Faculty of Medicine at Ludwig Maximilian
University Munich. Written informed consent was obtained from all participants’ parents, and all
participants provided written informed assent. This study is reported following the Consolidated
Standards of Reporting Trials (CONSORT) reporting guideline.
Study Design
The study was planned as a 2-arm parallel samples prospective multicenter randomized clinical trial
with 5 assessment points in a realistic clinical setting (Trial Protocol in Supplement 1). The originally
planned assessment points included: pre-IIPT (IIPT admission), post-IIPT (IIPT discharge), 2
assessments during the intervention period (at 3 and 6 months), and a follow-up assessment 12
months after discharge from IIPT. As a result of the COVID-19 pandemic and the consequential school
closings in Germany from March 18, 2020, onwards, the last assessment point was not stopped but
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excluded from these analyses because school absence, a core component of Chronic Pain Grading
(CPG), could no longer be reliably assessed.
For randomization, one of us (G.H.) created computer-generated randomization lists. Patients
were randomly assigned to 1 of 2 study groups: PAC or usual care. Blinding was not feasible.
Furthermore, the study design embodied typical characteristics of real-world trials,7 including the
application of few exclusion criteria, monitoring of (but not dictating) intervention frequency and
intensity, and a primary outcome measure consisting of aggregated patient-reported symptoms of
high importance to patients.
Study Sample
Inclusion criteria were pediatric patients aged 8 to 17 years admitted to IIPT from September 2018 to
October 2019, patient’s and at least 1 parent’s sufficient German language skills to complete
questionnaires and engage in the treatment (determined by clinician or nurse judgment), and
patient’s and parent’s agreement to study participation. In Germany, children with chronic pain are
eligible for IIPT if they fulfil at least 3 of the following criteria: reduced quality of life owing to pain,
unsuccessful unimodal pain treatment, medication misuse, presence of psychological comorbidity,
and presence of somatic comorbidity.8 Most of these patients are diagnosed with either International
Statistical Classification of Diseases and Related Health Problems, Tenth Revision, German
Modification (ICD-10-GM) code F45.40 or F45.41. The only exclusion criterion was withdrawal of
study participation. The sample size was determined a priori based on anticipated between-group
differences of the primary outcome of pain severity. Assuming an effect size of d = 0.5, an α level of
5%, and a power of 95%, we calculated that 92 patients per group were needed to detect an
advantage of PAC using a 1-sided Mann-Whitney test. Based on attrition rates of approximately 50%
reported by prior studies with comparable follow-ups, 419 patients were recruited to achieve the
desired sample size at follow-up. Figure 1 displays the participant recruitment flowchart.
Procedure
At each participating center, patients were assessed for eligibility immediately after IIPT admission.
Patients meeting the inclusion criteria were informed about the study and randomized after a least 1
parent’s written informed consent and the patient’s informed assent. Patients then completed the
first set of study questionnaires on an electronic tablet (pre-IIPT). The second set was completed on
discharge day (post-IIPT). For the following assessments, survey links were sent via email. All
participants received manualized IIPT9 (eAppendix 1 in Supplement 2). After discharge, the
intervention group received PAC while the control group received usual care.
Control Group: Usual Care
Patients in the control group received the standard aftercare after IIPT. This involved the option of a
1- to 1.5-hour refresher session with the treating pediatrician and psychotherapist 3 and 6 months
after discharge at the pain center (eAppendix 1 in Supplement 2). Additional sessions were optional
and by request.
Intervention Group: PAC
Patients in the intervention group were offered the same standard aftercare as the control group. In
addition, patients received personalized psychosocial aftercare (PAC). This intervention was based
on a standardized manual and guided by the concept of case-management. A detailed description of
PAC is provided in eAppendix 2, eTable 1, and the eFigure in Supplement 2.
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Measures
Patient Characteristics
Patient and pain characteristics (eg, demographics, pain location and duration) were assessed by the
German Pain Questionnaire for Children and Adolescents.10 This semi-structured instrument
assesses multiple aspects of the child's pain experience.
Primary Outcome
The primary outcome, pain severity, was derived using the Chronic Pain Grading (CPG),7 an
instrument to classify chronic pain patients into different severity grades (ranging from 0-4, with 0,
indicating no chronic pain; 1, low pain intensity and low disability; 2, high pain intensity and low
disability; 3, high disability, moderately limiting; and 4, high disability, severely limiting).11 Chronic
pain severity is calculated based on an algorithm including the patient’s rating of pain intensity
(overall mean of maximum rating and mean rating over the past 4 weeks), days absent from school,
and pain-related disability in everyday life11 (eAppendix 3 in Supplement 2). Maximum and mean pain
intensity within the past 4 weeks were reported on a numerical rating scale (NRS) (range, 0-10, with
0 indicating no pain and 10, strongest pain).12 Patients reported the number of days they had missed
school owing to pain within the past 4 weeks (maximum: 20 days). Pain-related disability was
measured using the validated Paediatric Pain Disability Inventory (PPDI),13,14 which consists of 12 self-
report items assessing pain-related disability in daily activities, eg, reading or sports, on a Likert scale
(range, 1-5, with 1 indicating never and 5, always; total score, 12-60, with higher values indicate
greater disability; internal consistency in this sample: Cronbach α = .87). The assessment of missed
school days and pain-related disability was not assessable at post-IIPT; thus, CPG was not calculable
at that point.
Figure 1. Study Participant Flowchart
512 Pediatric patients assessed for eligibility
93 Excluded
17 Did not meet inclusion criteria
76 Declined to participate
419 Patients randomized
168 With available data
115 Analyzed
152 With available data
201 Allocated to PAC
186 Received allocated intervention
15 Did not receive allocated intervention
15 Discontinued IIPT and withdrew from
study participation
27 Lost to follow-up at 6 mo
2 Wrong contact information
25 Survey not filled out
44 Excluded from analysis because
assessment period during
COVID-19 pandemic
34 Lost to follow-up at 3 mo
2 Wrong contact information
32 Survey not filled out
18 Lost to follow-up post-IIPT
186 With available data
107 Analyzed
161 With available data
218 Allocated to usual care
203 Received allocated intervention
15 Did not receive allocated intervention
15 Discontinued IIPT and withdrew from
study participation
38 Lost to follow-up at 6 mo
6 Wrong contact information
32 Survey not filled out
58 Excluded from analysis because
assessment period during
COVID-19 pandemic
42 Lost to follow-up at 3 mo
6 Wrong contact information
36 Survey not filled out
17 Lost to follow-up post-IIPT
IIPT indicates intensive interdisciplinary pain
treatment; PAC, psychosocial aftercare program.
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Secondary Outcomes
Secondary outcomes included pain-related characteristics, psychological measures, and treatment-
related measures. Pain intensity, pain-related school absence and pain-related disability were
included as pain-related characteristics.
Pain self-efficacy, a measure of one’s confidence in successfully dealing with pain by
implementing pain coping strategies,15 was measured with the validated Scale for Pain Self-Efficacy.
This tool consists of 11 items (eg, “Even when I am in pain, I can still do the things I like doing”), with
responses reported on a Likert scale (range, 0-4, with 0 indicating not true and 4, true; higher values
indicate greater self-efficacy). This scale has good internal consistency (in this sample: Cronbach
α = .86).
Depression and anxiety symptoms were assessed using the validated Revised Child Anxiety and
Depression Scale,16,17 a 47-item self-reported measure with a depression and an anxiety subscale (in
this sample: Cronbach α depression = .87; Cronbach α anxiety = .89). The items are reported on a
Likert scale (range, 0-3, with 0 indicating never to 3, always; higher values indicate greater
depression and anxiety symptoms).
Health-related quality of life was measured using the validated Kidscreen-27 (in this sample:
Cronbach α = .91).18 This measure consists of 5 dimensions (physical well-being, psychological well-
being, autonomy and parents, peers and social support, and school environment) summing up in a
total score. Items are rated on Likert scales (range, 0-5, with 1 indicating never and 5, always; higher
values indicate greater quality of life). This tool was not used at post-IIPT.
During PAC treatment, therapy adherence was reported at 3 and 6 months by patients on an
NRS (range, 0-10, with 0 indicating not at all to 10, completely agree) using the items “I was able to
implement the recommendations from IIPT” and “It was easy to implement the recommendations
from IIPT.” Additionally, PAC intensity (defined as the duration of all therapeutic contacts) and PAC
frequency (defined as the number of treatment contacts) were documented by social workers for the
whole duration of intervention.
At post-IIPT and during PAC-treatment, overall treatment satisfaction was reported by patients
on an NRS using the item “I am satisfied with my overall pain treatment.”
Statistical Analysis
All statistical analyses were conducted by 1 of us (G.H.) according to the approach defined in the
statistical analysis plan (Supplement 1). First, we examined whether study groups differed in
demographic and pain-related variables at pre-IIPT (continuous variables: t tests and Welch tests;
categorical variables: χ2 tests). Second, changes in the primary outcome (CPG, ordinal data) from
pre-IIPT to 3 and 6 months were calculated with the Wilcoxon test. Pain outcomes at 3 and 6 months
were compared with pre-IIPT scores because disability scores were not calculable at post-IIPT. We
then used the Mann-Whitney U test to compare the distribution of the primary outcome (CPG)
between groups at 3 and 6 months. Additionally, in the PAC group alone, Spearman correlations
between CPG improvement and PAC intensity and PAC frequency were assessed. Third, the
secondary outcomes (continuous data) were analyzed using mixed-model analyses (eAppendix 3 in
Supplement 2). Last, treatment satisfaction, adherence with treatment recommendations, and
perceived ease of adherence was compared between groups using t tests. Results of sensitivity
analyses using all available data and multiple imputation are described in eAppendix 4 in
Supplement 2.
We used R statistical software version 4.0.3 (R Project for Statistical Computing) for our
analyses. P values were 1-sided for our primary outcome and 2-sided for all secondary outcomes.
Statistical significance was set at P = .05. Data were analyzed from June 8 to September 4, 2020.
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Results
Patient Characteristics
A total of 419 pediatric patients with chronic pain (mean [SD] age, 14.3 [2.1] years; 303 [72.3%] girls;
116 [27.7%] boys) were randomized, with 218 patients assigned to usual care and 201 assigned to
PAC. Table 1 provides an overview of demographic and clinical characteristics of the study sample
and treatment groups. At pre-IIPT, the groups did not differ significantly in sociodemographic or
pain-related characteristics, and the median (IQR) CPG for both groups was 3 (2-4). A total of 102
(24.3%) patients were excluded from analyses because they supplied 6-month follow-up data after
the pandemic-related school-closings in Germany, and 95 patients (22.7%) dropped out of analyses
for other reasons (Figure 1). No systematic dropout was detected, as patients who completed the
assessment at 6 months (222 patients, including 107 patients in the usual care group and 115 patients
in the PAC group) did not differ in pre-IIPT-characteristics from patients who were excluded from
analyses owing to the COVID-19 pandemic, or patients who dropped out for other reasons (eTable 2
in Supplement 2).
Primary Outcome
In both treatment groups at 3 months, as well as at 6 months, the primary outcome CPG (pain
severity) showed significant improvements compared with pre-IIPT (usual care: 3 months, r = 0.36;
Table 1. Sociodemographic and Pain-Related Characteristics at Study Inclusion
Characteristic
Patients, No. (%)
All (N = 419) Usual care (n = 218) PAC (n = 201)
Sex
Girls 303 (72.3) 155 (71.1) 148 (73.6)
Boys 116 (27.7) 63 (28.9) 53 (26.4)
Age, mean (SD), y 14.3 (2.1) 14.3 (2.05) 14.3 (2.16)
Country of birth
Germany 406 (96.9) 211 (96.8) 195 (97.0)
Syria 1 (0.2) 1 (0.5) 0
Russia 1 (0.2) 0 1 (0.5)
Poland 2 (0.5) 1 (0.5) 1 (0.5)
Other 9 (2.2) 5 (2.2) 4 (2.0)
Pain locationsa
Head 288 (68.7) 150 (68.8) 138 (68.7)
Abdomen 109 (26.0) 55 (25.2) 54 (26.9)
Musculoskeletal 183 (43.7) 89 (40.8) 94 (46.8)
>1 main pain location 132 (31.5) 61 (28.0) 71 (35.4)
Pain duration
3-6 mo 37 (8.83) 19 (8.72) 18 (8.96)
6-12 mo 85 (20.3) 42 (19.3) 43 (21.4)
1-2 y 69 (16.5) 32 (14.7) 37 (18.4)
2-3 y 79 (18.9) 48 (22.0) 31 (15.4)
>3 y 149 (35.6) 77 (35.3) 72 (35.8)
Pain intensity, mean (SD)b
Maximum, mean (SD) 8.15 (1.74) 8.08 (1.88) 8.22 (1.58)
Overall 6.07 (1.89) 6.01 (1.95) 6.12 (1.84)
Missed school, mean (SD), db 5.44 (6.93) 5.24 (6.79) 5.66 (7.10)
CPG scorec
1 31 (7.4) 16 (7.3) 15 (7.5)
2 137 (32.7) 76 (34.9) 61 (30.3)
3 137 (32.7) 71 (32.6) 66 (32.8)
4 114 (27.2) 55 (25.2) 59 (29.4)
Abbreviations: CPG, Chronic Pain Grading; PAC,
psychosocial aftercare program.
a Multiple pain locations could be selected.
b In the past 4 weeks.
c At admission no participants had a CPG score of 0.
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95% CI, 0.17-0.41; P < .001; 6 months, r = 0.42; 95% CI, 0.26-0.57; P < .001; PAC: 3 months, r = 0.65;
95% CI, 0.53-0.74; P < .001; 6 months, r = 0.75; 95% CI, 0.65-0.80; P < .001). The CPG differences
between usual care and PAC groups showed a moderate effect at 6 months (median [IQR] CPG: usual
care, 2 [2-3]; PAC, 1 [1-2]; r = 0.30; 95% CI, 0.17-0.41; P < .001). Specifically, 25 patients (23.3%) in
the usual care group had reached a CPG 0 or 1, compared with 58 patients (50.4%) in the PAC group.
Both groups had a comparable percentage of patients in CPG 2 (usual care: 43 patients [40.2%]; PAC:
41 patients [35.7%]). The usual care group had a higher proportion of participants with CPG 3 or 4
(39 patients [36.4%]) than the PAC-group (16 patients [13.0%]). A detailed description of CPG
distribution is provided in eTable 3 in Supplement 2. Exploratory analyses also showed a difference
between groups at 3 months (r = 0.17; 95% CI, 0.06-0.28; P = .008). No significant correlations
were identified between CPG improvement at 6 months and PAC intensity (Spearman ρ = .15;
P = .52) or PAC frequency (Spearman ρ = .14; P = .64), indicating these measures were not linearly
associated with CPG improvement. The CPG distribution for all available data can be found in
eTable 4 in Supplement 2.
Secondary Outcomes
Means and mean differences of all secondary outcomes for each group and across time points are in
Table 2. Mixed-model analyses were conducted to determine whether differences existed by time
point, group, or time-by-group interaction for secondary pain and psychological outcomes.
As shown in Figure 2, all pain characteristics improved over time in both groups, but the
improvements were greater for the PAC-group compared with the usual care group. Mixed-model
analyses revealed a main effect of time for maximum and mean pain intensity (Table 3). Moreover,
there were significant interactions between time and group at 3 months and 6 months, indicating
that the improvement was greater in the PAC group than in the usual care group.
Regarding school absence, in addition to the main effect of time, the interaction coefficients
showed no significant difference between groups. For pain-related disability, there was a main effect
of time as well as greater reductions in in the PAC group than in the usual care group at 3 months and
6 months, as indicated by the significant time-by-group interaction.
In addition to a main effect of time, analyses of self-efficacy identified that trajectories diverged
at 3 and 6 months, per significant time-by-group interaction terms (Figure 2 and Table 3). While self-
efficacy increased at both time points in the PAC group, it decreased in the usual care group.
Main effects of time for depression and anxiety were only found at post-IIPT but not at 3 and 6
months. Significant time-by-group interactions emerged at 3 months and 6 months, because
depressive and anxiety symptoms returned to admission levels in the usual care group, while they
further decreased in the PAC group (Table 3).
Health-related quality of life showed no overall improvement over time. Significant time-by-
group interactions emerged at 3 months and 6 months owing to increasing quality of life in the PAC
group and stable values in the usual care group (Table 3).
Overall treatment satisfaction was high at post-IIPT, with groups not significantly differing
regarding this measure. However, patients in the PAC group reported a higher satisfaction at 6
months (change, −1.18; 95% CI, −1.90 to −0.045; P = .002) compared with the usual care group. At 6
months, the overall level of reported adherence did not significantly differ, but patients in the PAC
group reported that it was easier for them to adhere to the treatment recommendations (change,
−2.20; 95% CI, −3.02 to −1.38; P < .001). Details on these parameters are presented in eTable 5 in
Supplement 2. Further analyses for all available data can be found in eTables 6-8 in Supplement 2.
Discussion
This multicenter randomized clinical trial demonstrated the additive impact of PAC on regular IIPT.
PAC led to a lower pain severity and emotional impairment 3 and 6 months after discharge from IIPT
compared with usual care. In line with prior studies,3 we found that IIPT without specialized aftercare
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was highly effective in reducing overall pain severity for more than 60% of usual care patients (CPG
2). However, the reduction was significantly greater when IIPT was followed by PAC, with 86% of
these patients reaching CPG 2 or lower 6 months after discharge. The core component of the pain
severity measure we used was level of functioning, of which improvement is a central goal of IIPT and
of high clinical relevance.1 Against the background of the transtheoretical model5 patients receiving
PAC were regularly encouraged by their social worker to continue engaging with and adapting their
new strategies into everyday life. When difficulties were experienced, the social worker was available
to support the patient and the family.
PAC also had a beneficial impact on emotional functioning. At 3 and 6 months after IIPT, the PAC
group showed a continued reduction in anxiety and depressive symptoms. In contrast, the usual care
group did not experience this improvement and instead reverted to levels of psychological
symptoms experienced pre-IIPT. This corresponds with previous research3,19 that has found only
small long-term benefits associated with IIPT in anxiety and depression. Moreover, a study by
Moessner et al20 that evaluated the effectiveness of an aftercare program for adult patients with
lower back pain also reported a reversion in posttreatment trajectories for anxiety and depression in
the absence of an aftercare program.
Results of this randomized clinical trial illustrate that the patients’ pain self-efficacy was
improved by PAC. In contrast, pain self-efficacy in usual care patients decreased again after
discharge, although it remained higher than pre-IIPT levels. According to the theory of self-efficacy
by Bandura,21 there are 4 sources of efficacy: mastery experiences, vicarious experiences, verbal
persuasion, and emotional state. Most of these are likely to have been addressed by PAC. For
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Missed school days and pain-related disability were not assessable at time point 2. Time points are defined as 1, pre–intensive interdisciplinary pain treatment (IIPT); 2, post-IIPT; 3, 3
months post-IIPT; and 4, 6 months post-IIPT. CPG indicates Chronic Pain Grading; RCADS, Revised Child Anxiety and Depression Scale.
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example, the social workers may have facilitated more mastery experiences by motivating patients
to continue with their normal daily activities despite pain. An increase in self-efficacy beliefs likely
contributed to the improvement in functioning and emotional well-being observed in the PAC group,
as supported by previous work.15
Interestingly, no significant correlation was found between frequency or intensity of PAC and its
effectiveness. During PAC, patients determined the frequency of contact with the social worker,
which aligns with the “What you need is what you get” design advised for patient-controlled
analgesia studies.22 This design component allowed PAC to respond to the individual needs of
patients.
Limitations
This study has some limitations. As an inherent drawback of real-world trials, no detailed insight into
the treatment’s possible modes of action can be drawn. Thus, mechanisms underlying the positive
effects of PAC remain unclear. Furthermore, the high dropout rate might have resulted in a selection
bias. Moreover, this study lacks a follow-up assessment after the completion of PAC. Therefore, it
remains unclear whether and how long the positive effects of PAC can be maintained. Additionally,
the findings may not be generalizable to other countries.
Conclusions
This randomized clinical trial is the first study, to our knowledge, to investigate and find robust
support for the effectiveness of a PAC program for pediatric patients receiving IIPT. Future research
should investigate the modes of action and the long-term effects of the program.
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